LIPO-INJECTION W/LIDOCAINE NO METHIONINE W/PRES — Class II drug recall D-1209-2016
Terminated recall by Medaus, Inc., reported 2016-07-20, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-1209-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Medaus, Inc., Birmingham, AL, United States |
| Recall initiated | 2016-05-13 |
| Classified | 2016-07-08 |
| Reported by FDA | 2016-07-20 |
| Terminated | 2017-06-16 |
| Distributed | Nationwide (US) |
| Countries outside the US | JP, NZ |
| Quantity | 4,000 ml |
| Reason classes | sterility |
| Lot numbers | 151210-46, 160208-50 |
| Expiration dates | 2016-06-07, 2016-07-31 |
Product
LIPO-INJECTION W/LIDOCAINE NO METHIONINE W/PRES. (BENZYL ETOH 2%) ASCORBIC ACID-50MG, B1-50MG, B2-5 PO4-5MG, B-3-50MG, B5-5MG, B6-5MG, CYANO B12-100MCG,INOSITOL 25MG, CHOLINE CHL-25MG, LIDOCAINE-10MG/ML, 5ML Vials, MEDAUS PHARMACY
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1209-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.